Author Archive: Abigail Hirsch

Abigail Hirsch

Abigail is the Director of Events Communications at BIO. Although she has lived in the Washington, DC, area for nearly eight years, she still considers Virginia Beach home, especially with her parents and closest friends still in the area. According to Abigail, there is nothing better than sitting on the beach with a good book and cold drink. In her spare time, she enjoys visiting antique stores, finishing her twin sister Brooke’s sentences and spending time with her two boys, Frank her English bulldog, and JP her soon-to-be husband. Check back often for updates, Abigail’s take on BIO related events, and much more. And please, be kind, this is her first venture in to the blogging world!

Latest Posts

BioSpectrum Asia Survey Shows Promising Results for the Biosciences Industry

India2012_Thumbnail

BioSpectrum Asia recently completed a survey of close to 500 bioscience companies listed on different stock exchanges in both the Asia Pacific region (APAC) and in American stock exchanges, with total revenue of $139 billion (year end 2011) and market capitalization of $200 billion. The survey says of the top 20 companies in the region, comprising mostly of pharmaceutical, biotechnology and medical technology companies and focusing on R&D, manufacturing and marketing of life sciences products, Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,

2012 BIO Investor Forum: Looking Ahead to Investment Opportunities

partnering1

The biggest biotech news out of Washington in recent months was the Jumpstart Our Business Startups (JOBS) Act, which passed Congress overwhelmingly and was signed into law by President Obama in April.  For those not familiar, the JOBS Act creates a new category of issuers, called “emerging growth companies” (EGCs), which is defined as newly public companies with than $1 billion in annual revenues and a public float below $700 million. EGCs are given a Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , ,

Spotlight on India’s Emerging Biotech Sector

india-flag

India’s biotechnology sector is a burgeoning one, with more than 325 companies and some with revenues in the billions of dollars. According to the BioSpectrum-ABLE (Association of Biotechnology Led Enterprises) Biotech Industry Survey of 2011, the industry has grown by 21.5% in 2006-2011, surging to $4 billion. Furthermore, India is the world’s largest manufacturer of vaccines and the growth of India vaccine makers arises from their ability to develop and produce high-quality vaccines with low Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

2012 BIO Convention in China: Highlighting Cross-Border Partnering in Biotechnology

biochina-flag-btn

In its second year, the BIO Convention in China will be held October 24-25, 2012 in Shanghai, China. BIO China will bring together executives from biotechnology, pharmaceutical companies and investment firms from North America, Europe and Asia to meet and explore business opportunities with China’s emerging biotech and rapidly expanding pharmaceutical sectors. Read more to learn why you can’t miss this event! Revenues from biologics are skyrocketing in China, posting an annual growth rate of Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , ,

2012 BIO India International Conference: Top Five Reasons to Attend

biocon

The third annual BIO India International Conference will be held September 12-13 at the Grand Hyatt in Mumbai, India. BIO India will feature high-level keynote speakers, education panels on the latest trends, networking opportunities, company presentations and partnering meeting opportunities through the BIO One-on-One Partnering™ system. The event is particularly relevant and timely for those looking to learn more about India’s rapidly growing global presence in the life sciences. Read more to learn the top Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,